Legend Biotech Gross Profit 2019-2021 | LEGN

Legend Biotech annual/quarterly gross profit history and growth rate from 2019 to 2021. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Legend Biotech gross profit for the quarter ending September 30, 2021 was $0.017B, a 31.53% increase year-over-year.
  • Legend Biotech gross profit for the twelve months ending September 30, 2021 was $0.095B, a 59.64% increase year-over-year.
  • Legend Biotech annual gross profit for 2020 was $0.082B, a 27.03% increase from 2019.
  • Legend Biotech annual gross profit for 2019 was $0.064B, a 2.15% increase from 2018.
  • Legend Biotech annual gross profit for 2018 was $0.063B, a INF% increase from .
Legend Biotech Annual Gross Profit
(Millions of US $)
2020 $82
2019 $64
2018 $63
Legend Biotech Quarterly Gross Profit
(Millions of US $)
2021-09-30 $17
2021-06-30 $22
2021-03-31 $14
2020-12-31 $42
2020-09-30 $13
2020-06-30 $13
2020-03-31 $14
2019-12-31 $20
2019-09-30 $21
2019-06-30 $11
2019-03-31 $13
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.389B $0.076B
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's lead product consist LCAR-B38M/JNJ-4528, which are in clinical stage. Legend Biotech Corporation is based in Cayman Islands.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $144.122B 9.11
Bio-Rad Laboratories (BIO.B) United States $18.677B 37.90
QIAGEN (QGEN) Netherlands $11.053B 18.72
Biohaven Pharmaceutical Holding (BHVN) United States $8.002B 0.00
Emergent Biosolutions (EBS) United States $2.809B 10.10
Arcus Biosciences (RCUS) United States $2.516B 0.00
Myovant Sciences (MYOV) United Kingdom $1.432B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.186B 0.00
Zymeworks (ZYME) Canada $0.697B 0.00
Ambrx Biopharma (AMAM) United States $0.230B 0.00
SQZ Biotechnologies (SQZ) United States $0.229B 0.00
Enzo Biochem (ENZ) United States $0.160B 20.69